ANNUAL REPORT FOR YEAR ENDED 8-31-2010

Company

AYTU BIOPHARMA, INC

Filed

November 29, 2011

Period of Report

August 31, 2011

Accession Number

0001354488-11-004793

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →